1. 1977 Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC). (September 2015) Authors: Bardia, A.; Cameron, J.S.; Venkatesan, K.; Robinson, D.; Porter, D.; Kim, S.B.; Parton, M.; Kümmel, S.; Estevez, L.G.; Huang, C.S.; Cortes Castan, J.; Ruiz-Borrego, M.; Telli, M.; Martín Martorell, P.; Lopez, R.; Beck, J.T.; Ismail-Khan, R.; Chen, S.C.; Hurvitz, S.; Mayer, I. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗